Literature DB >> 32497296

Advancing physiological maturation in human induced pluripotent stem cell-derived cardiac muscle by gene editing an inducible adult troponin isoform switch.

Matthew Wheelwright1, Jennifer Mikkila1, Fikru B Bedada1, Mohammad A Mandegar2, Brian R Thompson1, Joseph M Metzger1.   

Abstract

Advancing maturation of stem cell-derived cardiac muscle represents a major barrier to progress in cardiac regenerative medicine. Cardiac muscle maturation involves a myriad of gene, protein, and cell-based transitions, spanning across all aspects of cardiac muscle form and function. We focused here on a key developmentally controlled transition in the cardiac sarcomere, the functional unit of the heart. Using a gene-editing platform, human induced pluripotent stem cell (hiPSCs) were engineered with a drug-inducible expression cassette driving the adult cardiac troponin I (cTnI) regulatory isoform, a transition shown to be a rate-limiting step in advancing sarcomeric maturation of hiPSC cardiac muscle (hiPSC-CM) toward the adult state. Findings show that induction of the adult cTnI isoform resulted in the physiological acquisition of adult-like cardiac contractile function in hiPSC-CMs in vitro. Specifically, cTnI induction accelerated relaxation kinetics at baseline conditions, a result independent of alterations in the kinetics of the intracellular Ca2+ transient. In comparison, isogenic unedited hiPSC-CMs had no cTnI induction and no change in relaxation function. Temporal control of adult cTnI isoform induction did not alter other developmentally regulated sarcomere transitions, including myosin heavy chain isoform expression, nor did it affect expression of SERCA2a or phospholamban. Taken together, precision genetic targeting of sarcomere maturation via inducible TnI isoform switching enables physiologically relevant adult myocardium-like contractile adaptations that are essential for beat-to-beat modulation of adult human heart performance. These findings have relevance to hiPSC-CM structure-function and drug-discovery studies in vitro, as well as for potential future clinical applications of physiologically optimized hiPSC-CM in cardiac regeneration/repair. ©AlphaMed Press 2020.

Entities:  

Keywords:  TNNI; cardiac; gene editing; induced pluripotent stem cells; myocardial contraction; myocytes

Mesh:

Substances:

Year:  2020        PMID: 32497296      PMCID: PMC7529900          DOI: 10.1002/stem.3235

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  46 in total

1.  Myosin heavy chain isoform expression in the failing and nonfailing human heart.

Authors:  S Miyata; W Minobe; M R Bristow; L A Leinwand
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

2.  Chimera analysis of troponin I domains that influence Ca(2+)-activated myofilament tension in adult cardiac myocytes.

Authors:  M V Westfall; F P Albayya; I I Turner; J M Metzger
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

3.  Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.

Authors:  Jirko Kühnisch; Christopher Herbst; Nadya Al-Wakeel-Marquard; Josephine Dartsch; Manuel Holtgrewe; Anwar Baban; Giulia Mearini; Juliane Hardt; Konstantinos Kolokotronis; Brenda Gerull; Lucie Carrier; Dieter Beule; Stephan Schubert; Daniel Messroghli; Franziska Degener; Felix Berger; Sabine Klaassen
Journal:  Clin Genet       Date:  2019-10-22       Impact factor: 4.438

4.  Troponin I chimera analysis of the cardiac myofilament tension response to protein kinase A.

Authors:  M V Westfall; I Turner; F P Albayya; J M Metzger
Journal:  Am J Physiol Cell Physiol       Date:  2001-02       Impact factor: 4.249

Review 5.  Influence of altered inotropy and lusitropy on ventricular pressure-volume loops.

Authors:  A M Katz
Journal:  J Am Coll Cardiol       Date:  1988-02       Impact factor: 24.094

6.  Troponin I isoform expression in human heart.

Authors:  N M Hunkeler; J Kullman; A M Murphy
Journal:  Circ Res       Date:  1991-11       Impact factor: 17.367

7.  Cardiac transgenic and gene transfer strategies converge to support an important role for troponin I in regulating relaxation in cardiac myocytes.

Authors:  So-ichiro Yasuda; Pierre Coutu; Sakthivel Sadayappan; Jeffrey Robbins; Joseph M Metzger
Journal:  Circ Res       Date:  2007-07-05       Impact factor: 17.367

8.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.

Authors:  Dirk Hockemeyer; Frank Soldner; Caroline Beard; Qing Gao; Maisam Mitalipova; Russell C DeKelver; George E Katibah; Ranier Amora; Elizabeth A Boydston; Bryan Zeitler; Xiangdong Meng; Jeffrey C Miller; Lei Zhang; Edward J Rebar; Philip D Gregory; Fyodor D Urnov; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2009-08-13       Impact factor: 54.908

Review 9.  Cardiomyocyte Regeneration: A Consensus Statement.

Authors:  Thomas Eschenhagen; Roberto Bolli; Thomas Braun; Loren J Field; Bernd K Fleischmann; Jonas Frisén; Mauro Giacca; Joshua M Hare; Steven Houser; Richard T Lee; Eduardo Marbán; James F Martin; Jeffery D Molkentin; Charles E Murry; Paul R Riley; Pilar Ruiz-Lozano; Hesham A Sadek; Mark A Sussman; Joseph A Hill
Journal:  Circulation       Date:  2017-07-06       Impact factor: 29.690

Review 10.  Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.

Authors:  Rosalinda Madonna; Linda W Van Laake; Sean M Davidson; Felix B Engel; Derek J Hausenloy; Sandrine Lecour; Jonathan Leor; Cinzia Perrino; Rainer Schulz; Kirsti Ytrehus; Ulf Landmesser; Christine L Mummery; Stefan Janssens; James Willerson; Thomas Eschenhagen; Péter Ferdinandy; Joost P G Sluijter
Journal:  Eur Heart J       Date:  2016-04-07       Impact factor: 29.983

View more
  5 in total

1.  Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca2+-Activation of Mature and Immature Mouse Cardiac Myofilaments.

Authors:  Monika Halas; Paulina Langa; Chad M Warren; Paul H Goldspink; Beata M Wolska; R John Solaro
Journal:  Mol Pharmacol       Date:  2022-03-02       Impact factor: 4.054

2.  Cyclic Stretching Induces Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes through Nuclear-Mechanotransduction.

Authors:  Myeongjin Song; Yongjun Jang; Seung-Jong Kim; Yongdoo Park
Journal:  Tissue Eng Regen Med       Date:  2022-03-08       Impact factor: 4.451

3.  Myofibrillar Structural Variability Underlies Contractile Function in Stem Cell-Derived Cardiomyocytes.

Authors:  Kathryn Ufford; Sabrina Friedline; Zhaowen Tong; Vi T Tang; Amani S Dobbs; Yao-Chang Tsan; Stephanie L Bielas; Allen P Liu; Adam S Helms
Journal:  Stem Cell Reports       Date:  2021-02-11       Impact factor: 7.765

4.  Monitoring the maturation of the sarcomere network: a super-resolution microscopy-based approach.

Authors:  Anna Skorska; Lisa Johann; Oleksandra Chabanovska; Praveen Vasudevan; Sophie Kussauer; Maximilian Hillemanns; Markus Wolfien; Anika Jonitz-Heincke; Olaf Wolkenhauer; Rainer Bader; Hermann Lang; Robert David; Heiko Lemcke
Journal:  Cell Mol Life Sci       Date:  2022-02-23       Impact factor: 9.207

5.  Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue.

Authors:  Shi Shen; Lorenzo R Sewanan; Stephanie Shao; Saiti S Halder; Paul Stankey; Xia Li; Stuart G Campbell
Journal:  Stem Cell Reports       Date:  2022-08-04       Impact factor: 7.294

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.